Literature DB >> 31618089

Ibrutinib-Associated Reversible Cardiomyopathy.

Shih-Hsin Liang1,2, Chang-Fang Chiu2,3, Li-Yuan Bai2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31618089     DOI: 10.1200/JOP.19.00334

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  1 in total

1.  Reversible Systolic Heart Failure in a Patient on Ibrutinib Chemotherapy.

Authors:  Misbahuddin Khaja; Hitesh Gurjar; Laura Yapor; Minu C Abraham; Nolberto Hernandez; Asim Haider
Journal:  Cureus       Date:  2022-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.